Roots Analysis

OCTOBER 24, 2023

Contract Manufacturing in HPAPIs and Cytotoxic Drugs The HPAPI manufacturing process is complex and is associated with several challenges. The production of such drug products requires specialized working environments, stringent manufacturing protocols, skilled labor and high costs.

Manufacturing 40

Manufacturing Hormones Contamination Contract Manufacturing 40

Camargo

JANUARY 19, 2021

They also have multiple clients, and thus by definition have many demands on their time and resources, particularly their manufacturing equipment and analytical capabilities. Having a quality agreement in place is critical.

Production 135

Production Branding Contract Manufacturing Manufacturing 135

Drug Discovery World

DECEMBER 14, 2023

The Institute has particular strengths in understanding how cancer hijacks the cell’s energy factories and how it manipulates the body to provide the resources it needs to grow and spread, like protein scaffolding and blood vessels. “Key to the success of our Glasgow site is its integration in the Cancer Research UK Scotland Institute.

Drugs 75

Drugs Life Science Research Scientist 75

pharmaphorum

JULY 15, 2022

The industry also pooled its own resources by relying on outside capacity to an enormous degree. Though the use of outsourcing manufacturing services is now common across the industry, it is extremely unusual to see large pharma companies rely on the manufacturing capacity of fellow big pharma entities, as was seen during the pandemic.

Vaccination 114

Vaccination Vaccine Manufacturing Production 114

The Pharma Data

AUGUST 7, 2020

to manufacture and supply Gilead’s investigational antiviral remdesivir, as one of multiple external manufacturing organizations supporting efforts to scale up supply of the investigational treatment for COVID-19. (NYSE: PFE) today announced a multi-year agreement with Gilead Sciences, Inc.

Manufacturing 52

Manufacturing Containment Contract Manufacturing Development 52

XTalks

FEBRUARY 27, 2024

However, the FDA extended its review due to its own issues of resource limitations. According to Iovance, Amtagvi is manufactured using a proprietary process to collect and expand a patient’s unique T cells from a portion of their tumor, and then returning billions of the patient’s T cells back to the body to fight their cancer.

FDA Approval 52

FDA Approval Manufacturing In-Vivo Trials 52

The Pharma Data

SEPTEMBER 11, 2021

By leveraging our unique ability to manufacture DNA at scale, we can construct proprietary antibody libraries precisely designed to match sequences that occur in the human body. This library of libraries gives our partners an integral and unbiased resource for antibody therapeutic discovery and optimization. Source link: [link].

Antibody 52

Antibody DNA Containment Manufacturing 52

The Pharma Data

MARCH 22, 2022

Pfizer continues to invest to support the manufacturing and distribution of PAXLOVID, including exploring potential contract manufacturing options. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines.

In-Vitro 52

In-Vitro Contract Manufacturing Manufacturing Production 52

Fossil Remedies

JULY 18, 2019

Also, you don’t bother about the maintenance of the manufacturing unit. These two aspects need a lot of resources and energy. As the owner of the business, you don’t have to be worried about starting capital. The third-party model saves you from the hassles. Quality of production.

Manufacturing 60

Manufacturing Pharma Companies Production Pharma Production 60

The Pharma Data

DECEMBER 23, 2020

INOVIO is also assessing nonclinical efficacy of INO-4800 in several animal challenge models with Public Health England (PHE) and Commonwealth Scientific and Industrial Research Organization (CSIRO) in Australia.

DNA 40

DNA Vaccination Vaccine Immune Response 40

Drug Discovery World

FEBRUARY 22, 2023

Managing the drug life-cycle will become even more important As products in the pharma portfolio mature and are faced with an ever-decreasing exclusivity period engaging with external partners early and developing trust with contract manufacturers through shared knowledge will enable the organisations to compete against generic competitors.

Development 52

Development Drugs Manufacturing Contract Manufacturing 52

The Pharma Data

JULY 21, 2021

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines.

Manufacturing 52

Manufacturing Vaccination Vaccine Clinical Trials 52

The Pharma Data

NOVEMBER 1, 2021

With its MORE GREEN pillar, Boehringer Ingelheim intends to become even more environmentally sustainable, continuing the significant reduction in the company’s greenhouse gas emissions, energy and resource use, as well as water footprint. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective.

Contract Manufacturing 52

Contract Manufacturing Development Production Manufacturing 52

The Pharma Data

MARCH 8, 2022

As one of our contract manufacturers since November 2020, Aspen has been a significant supplier within the Johnson & Johnson global network. Europe, Africa, Asia and Latin America as we sought to generate evidence across multiple geographies and diverse, at-risk populations, including in resource-limited settings.

Manufacturing 40

Manufacturing Vaccination Vaccine Contract Manufacturing 40

Drug Discovery World

FEBRUARY 2, 2023

So extreme and so complex are the special safety and handling measures required during the manufacture of RRx-001 that only a handful of highly specialised contract manufacturing organisations (CMOs) in the world possess the necessary qualifications, expertise, and experience to make and store it.

Manufacturing 52

Manufacturing Clinical Trials Clinical Trials Drugs 52

The Pharma Data

MARCH 20, 2021

The truth is that internal resources in today’s businesses are spread paper-thin, and even when there are inhouse subject matter experts who have the writing chops, they generally don’t have the time to devote to producing content.

Development 52

Development Marketing Branding Contract Manufacturing 52

The Pharma Data

NOVEMBER 15, 2020

Prior to BioMotiv, Mr. Shah was Chief Executive Officer, member of the board of directors, and a co-founder of BioEnterprise, a business that assists companies in securing resources and funding to support their growth.

Clinical Trials 40

Clinical Trials Clinical Trials Production Trials 40

The Pharma Data

JUNE 24, 2021

The production capacity has consistently grown due to continued enhancements to the vaccine’s supply chain, which include expanding existing facilities, adding more suppliers, and bringing on additional Pfizer/BioNTech sites and contract manufacturers around the world to produce the vaccine.

Vaccination 52

Vaccination Vaccine Manufacturing Clinical Trials 52